Intangible Assets in Pharmaceutical Companies in the Czech Republic
Intangible Assets in Pharmaceutical Companies in the Czech Republic

Author(s): Patrik Svoboda, Hana Bohušová, Lucie Semerádová
Subject(s): National Economy, Business Economy / Management, Health and medicine and law
Published by: Masarykova univerzita nakladatelství
Keywords: Intangible Assets; Fixed Assets; GDP; Goodwill; IFRS;
Summary/Abstract: Due to the technical and scientific progress, the cost structure of business entities changes significantly. An important item of costs are costs associated with intangible assets such as software, patents, licenses, copyrights and goodwill. We can assume that the share of these assets in total assets of companies has changed over time. The paper is focused on the evaluation of the share of intangible assets in total assets of entities involved in chemistry in the Czech Republic. The analyzed sample of companies represents entities preparing financial statements in accordance with the Czech Accounting Legislation. The results are compared with the companies operating in the chemical industry and prepare their financial statements according to IFRS. The aim of this paper is to evaluate the materiality of this category, its structure and its changes over time and to identify possible reasons for this situation.

• Details
• Contents